Mountain Home’s planned medical marijuana dispensary has six owners, a Little Rock publication reports.

An Arkansas Business review of medical marijuana dispensary applications shows that Mountain Home’s Plant Family Therapeutics’ ownership group consists of James Compton (40 percent), Clint Mickle (30 percent), Linda McAnally (15 percent), Keith Schluterman (5 percent), Adam Schluterman (5 percent) and Jeff McAnally (5 percent).

According to the group’s dispensary application, Mickle will serve as the business’ CEO, while Compton will serve as the chief financial officer.

Plant Family Therapeutics was one of 32 businesses awarded a license earlier this month to sell medical marijuana to patients with qualifying medical conditions. The permits were awarded by the Arkansas Medical Marijuana Commission from a pool of nearly 200 applicants.

Would-be dispensaries being awarded permits had until Jan. 17 to pay a $15,000 licensing fee and post a $100,000 performance bond before the state issued a permit. The Baxter Bulletin’s calls Tuesday to the Marijuana Commission offices in Little Rock requesting confirmation that Plant Family Therapeutics had paid its licensing fee and posted its bond were not returned.

Earlier this month: Marijuana dispensary coming to Mountain Home

A Plant Family Therapeutics Facebook page lists an address of 5172 Highway 62 E as the dispensary’s address. That address is a wooded plot about a half a mile east of Cranfield Road.

“Plant Family Therapeutics is one of 32 applicants to earn a medical cannabis dispensary license in the great state of Arkansas and we are happy to announce we will be opening a cultivating dispensary in Mountain Home,” a Jan. 15 post on the Facebook page states in part. “Plant Family Therapeutics brings together some of the state’s leading healthcare professionals, horticultural experts, physicians and business leaders with a singular focus to help patients access a natural therapeutic option for pain management and other qualifying conditions.”

In the comments section of that Jan. 15 post, one Facebook user suggests that the dispensary carry the “Blue Dream” strain of cannabis to treat fibromyalgia. According to cannabis information resource Leafly.com, Blue Dream is a popular hybrid strain of cannabis that delivers swift symptom relief without heavy sedative effects. It is a popular daytime medicine for patients treating pain, depression and nausea, the website states.

“We are going to work closely with the state’s five cultivation facilities to ensure we have a variety of strains to address all of the qualifying conditions,” responded Elizabeth Claire Mickle, whose Facebook profile lists her as the wife of Clint Mickle. “As PFT evaluates the strains that we will grow ourselves, we will certainly keep your request in mind.”

State regulators estimate that the first dispensaries will open in the spring, selling cannabis grown at one of five large-scale cultivation facilities. Those facilities are currently under construction, with one — BOLD Team in Cotton Plant — having already begun growing marijuana.

Some dispensaries have elected to grow up to 50 mature cannabis plants on site, but information on whether Plant Family Therapeutics was one of those businesses was unavailable Tuesday.

More: New legislation seeks to expand medical marijuana qualifications

Approved by the state’s voters in 2016, Amendment 98 to the Arkansas Constitution allows patients suffering from cancer; glaucoma; HIV or AIDS; hepatitis C; amyotrophic lateral sclerosis; Tourette syndrome; Crohn’s disease; ulcerative colitis; post-traumatic stress disorder; severe arthritis; fibromyalgia; or Alzheimer’s disease to use medical marijuana. Various medical conditions causing “intractable pain” also qualify patients for the medical marijuana program.

The Arkansas Department of Health has approved more than 6,700 patients for medical marijuana ID cards. Applicants must pay a $50 yearly registration fee, provide a copy of a valid Arkansas driver’s license or other state-issued ID and obtain a written certification from a physician that the patient has a qualifying medical condition.

Medical marijuana ID cards are expected to be issued starting next month, the agency has said.